These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3316761)

  • 1. [Effects of angiotensin converting enzyme inhibitor (captopril) on erythrocyte sodium ion transport systems in patients with essential hypertension].
    Fujito K; Yokomatsu M; Numahata H; Ishiguro N; Koide H
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):731-8. PubMed ID: 3316761
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of angiotensin-converting enzyme inhibitor on erythrocyte sodium ion transport in essential hypertension.
    Fujito K; Yokomatsu M; Numahata H; Ishiguro N; Koide H
    Life Sci; 1992; 51(26):2079-87. PubMed ID: 1335539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Membrane transport of cations in erythrocytes during treatment of essential hypertension with angiotensin-converting enzyme inhibitors].
    Smrcková I; Stríbrná J; Petrásek R; Skibová J; Lánská V
    Cas Lek Cesk; 1992 May; 131(10):294-6. PubMed ID: 1638592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of captopril, canrenoate potassium, and atenolol. Relations with red blood cell sodium transport and renin.
    Niutta E; Cusi D; Colombo R; Tripodi G; Pellizzoni M; Pati P; Cesana B; Alberghini E; Barlassina C; Bianchi G
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):364-71. PubMed ID: 3063286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibition on Na+/H(+)-exchange and Ca(2+)-efflux in human erythrocytes.
    Lijnen P; Arabidze CG; Petrov V
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):125-8. PubMed ID: 9151288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects].
    Seto S; Kaku T; Shinagawa T; Matsumoto Y; Doi Y; Tasaki S; Murayama M; Aoi W; Kuramochi M; Hashiba K
    Nihon Naika Gakkai Zasshi; 1980 Nov; 69(11):1439-46. PubMed ID: 7017040
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Volume of the extracellular liquid and renal function during short-term administration of angiotensin converting enzyme inhibitors in essential hypertension].
    Samà B; Semplicini A; Buzzacarini F; Rubino N; Marzola M; Mozzato MG; Casolino P; Pessina AC
    G Ital Cardiol; 1989 May; 19(5):428-32. PubMed ID: 2670657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
    J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrocyte sodium-potassium co-transport in hypertension.
    de Zeeuw D; Jilderda JF; Tepper T
    Proc Eur Dial Transplant Assoc; 1983; 20():507-13. PubMed ID: 6657675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of manipulation of sodium balance on erythrocyte sodium transport.
    el Ashry A; Heagerty AM; Alton SM; Bing RF; Swales JD; Thurston H
    J Hum Hypertens; 1987 Sep; 1(2):105-11. PubMed ID: 3333521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport.
    de la Sierra A; Insa R; Compte M; Martínez-Amenós A; Sierra C; Hernández-Herrero G; Coca A
    Am J Hypertens; 1995 Jun; 8(6):622-5. PubMed ID: 7662247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.